<Anchor> The

first dose of Pfizer vaccine, which was temporarily suspended due to insufficient supply, will resume after 6 days. It covers 2.40 million people, including seniors aged 75 and over. As the vaccine is now available to some extent, the government is reviewing the benefits to the vaccinators.

This is reporter Han Ji-yeon.

<Reporter> In this

month, the first dose of the Pfizer vaccine for senior citizens over 75 years of age, residents of elderly facilities, and workers has practically stopped.

As the second vaccination of seniors who received the vaccine at the beginning of last month began in earnest, the amount of supplies for the first vaccination was insufficient.

As the second vaccination was over, the government decided to resume the delayed first vaccination from the 22nd.

The target audience is 2,400,000 people, including seniors aged 75 and over, residents of elderly facilities, and workers.

If the remaining 720,000 doses and 4.44 million doses by next month come in, then the amount will be sufficient until the 2nd vaccination of these unvaccinated people.

For vaccination reservations, staff from towns and villages nationwide contact the target person this week to confirm the schedule.

[Sonyoungrae / Central accidents probation office social strategy Lieutenant: first, the more you apply can be vaccinated choose the nearest desired institutions and desired date]

There being made mostly also a secondary immunization AstraZeneca vaccine, the first dose from 27 days back It is in earnest.

It is correct from 65 to 74 years old and people with chronic severe respiratory disease.

AstraZeneca vaccine was supplied with an additional 1.332,000 doses of the vaccine last week, followed by an additional 1068,000 doses of the AstraZeneca vaccine tomorrow (17th).

The government has decided to quickly review the various benefits for those who have been vaccinated.

[Boo-gyeom Kim/Prime Minister: Please speed up the discussions for mutual recognition of vaccinations with major countries.]

After vaccination, additional benefits such as exemption from self-isolation upon entry and exit are being reviewed.

(Video coverage: Jeong Seong-hwa, video editing: Lee So-young)